Resources Contact Us Home
Hybrid immunoglobulin-thrombolytic enzyme molecules which specifically bind a thrombus, and methods of their production and use

Image Number 12 for United States Patent #5609869.

Hybrid immunoglobulin-enzyme molecules are provided which are composed of antibodies, or derivatives or fragments thereof, which specifically bind an arterial or venous thrombus that are operably linked to the enzymatically active portions of thrombolytic enzymes such as plasminogen activators. In a preferred embodiment the hybrid molecules specifically bind to fibrin and have fibrinolytic activity. The hybrid molecules of the present invention may be produced by any means, including chemical conjugation, or by means of recombinant DNA, genetic engineering and/or hybridoma technology. Methods for making and using the molecules in diagnosis and therapy are also disclosed.

  Recently Added Patents
Method and apparatus for allocating and obtaining IP address
Method and apparatus for disease diagnosis and screening using extremely low frequency electromagnetic fields
Materials for organic electroluminescent devices containing substituted 10-benzo[c]phenanthrenes
Portable electric circular saw
Method and apparatus for transmitting and receiving a signal in a communication system
Cover panel for frame based door lock
2,5-disubstituted piperidine orexin receptor antagonists
  Randomly Featured Patents
Component mounting process for printed circuit boards
Anticholinergic compounds, compositions and methods of treatment
Soft tissue diagnostic apparatus and method
Circuit and method for detecting if a sum of two multibit numbers equals a third multibit constant number prior to availability of the sum
Inspection apparatus for performing inspections
Multiple, hinged support core apparatus
Carburetor with starting system
Packet transfer method and packet transfer node
Armature with coated laminate bundle